Hesperidin mitigated high blood pressure and cardiac remodeling by reducing the left ventricular hypertrophy and fibrosis associated with down-regulations of TGF-β1 and TNF-R1 protein expression and a reduction of plasma TGF-β1 levels in l-NAME-induced hypertension in rats. Here, TNFRSF1A is linked to hypertensive disorder.